Document:

Warrant to Purchase Common Stock (No. 201004-010)

 Exhibit 10.15 
 THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION
SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS. 
  

			
	WARRANT NO. 201004-010	  	Date: April 15, 2010

 WARRANT TO PURCHASE COMMON STOCK 
 AutoGenomics, Inc., a Delaware corporation (the “Company”), hereby certifies that Terrance A. Noonan (the “Holder”), is entitled to purchase, on the terms and
conditions contained herein, 28,400 fully paid, validly issued and nonassessable shares (the “Warrant Shares”) of common stock, no par value, of the Company (the “Common Stock”), at an initial exercise price of
$7.00 per Warrant Share (the “Exercise Price”). This Warrant has been approved by the Board of Directors of the Company and is issued pursuant to the terms of that certain Subscription Agreement, dated as of the date hereof, by and
between the Company and the Holder (the “Subscription Agreement”). The number of Warrant Shares and the Exercise Price are subject to adjustment as provided in Section 2 below. 

This Warrant is subject to the following terms and conditions: 
 1. Exercisability and Exercise. 
 1.1 Method of Exercise. This
Warrant may be exercised in whole at the option of the Holder at any time and from time to time from the one (1) year anniversary of the date hereof through and including the five (5) year anniversary of the date hereof (the
“Exercise Period”), by delivering to the Company payment of the aggregate Exercise Price for the Warrant Shares being purchased by check or wire transfer, together with an executed Notice of Exercise in the form attached as
Exhibit I hereto. 
 1.2 Effectiveness of Exercise; Procedure. The exercise of this Warrant shall be deemed to
have been effected immediately prior to the close of business on the day on which the Holder delivers the Notice of Exercise to the Company together with payment of the Exercise Price and satisfies all of the requirements of this Section 1.
Upon such exercise, the Holder will be deemed a shareholder of record of the Warrant Shares with all rights of a shareholder (including, without limitation, all voting rights with respect to such Warrant Shares and all rights to receive any
dividends with respect to such Warrant Shares). In the event of any exercise of the rights represented by this Warrant, certificates for the shares of Common Stock so purchased shall be delivered to

  
 Page 1

 
the Holder within a reasonable time by the transfer agent of the Company by crediting the account of the Holder’s broker with The Depositary Trust Company through its Deposit Withdrawal
Agent Commission system if the Company is a participant in such system, and otherwise by physical delivery to the address specified in the Notice of Exercise. The Company shall not be required to issue fractional shares upon the exercise of this
Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Holder shall be entitled, at its option, to receive either (a) a cash payment equal to the excess of the fair market value, as determined by the Board
of Directors of the Company in good faith, for such fractional share above the Exercise Price for such fractional share (as mutually determined by the Company and the Holder) or (b) a whole share if the Holder tenders the Exercise Price for one
whole share. 
 2. Adjustments. 
 2.1 Reorganizations, Mergers, Recapitalizations and Reclassifications. 

(a) Change of Control. If at any time a Change of Control (as defined below) occurs and, pursuant to the terms of such Change of
Control, shares of common stock of the successor or acquiring corporation, or any cash, shares of stock or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition to or in lieu
of common stock of the successor or acquiring corporation (“Other Property”), are to be received by or distributed to the holders of Common Stock of the Company, then the Holder shall have the right thereafter to receive upon
exercise of this Warrant (and this Warrant shall thereafter be exercisable only for) the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and Other Property receivable
upon or as a result of such Change of Control by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Change of Control. In case of any such Change of Control, the successor or acquiring
corporation (if other than the Company) shall expressly assume the due and punctual observance and performance of each and every covenant and condition of this Warrant to be performed and observed by the Company and all the obligations and
liabilities hereunder, subject to such modifications as may be deemed appropriate (as determined in good faith by resolution of the Board of Directors of the Company) in order to provide for adjustments of the Warrant Shares for which this Warrant
is exercisable which shall be as nearly equivalent as practicable to the adjustments provided for in this Section 2.1(a). For purposes of this Section 2.1(a), “common stock of the successor or acquiring corporation” shall include
stock of such corporation of any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject to redemption. The foregoing provisions of this Section 2.1(a) shall similarly
apply to any successive Change of Control. As used in this Warrant, a “Change of Control” shall mean (i) a transaction or series of transactions (other than an offering of common stock of the Company to the general public
through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Securities Exchange
Act of 1934, as amended from time to time (the “Exchange Act”)) (other than the Company, any of its subsidiaries, an employee benefit plan maintained by 

  
 Page 2

 
the Company or any of its subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company)
directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding
immediately after such acquisition; or (ii) the consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (A) a merger, consolidation, reorganization or
business combination, (B) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (C) the acquisition of assets or stock of another entity, in each
case other than a transaction (1) which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the
Successor Entity (as defined below)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and (2) after which no person or group
beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this Section 2.1(a)(ii)(C)(2) as
beneficially owning 50% or more of combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction. As used in this Section 2.1(a)(ii)(C), the
“Successor Entity” shall mean, as applicable, the Company or the person that, as a result of the Change of Control, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the
Company’s assets or otherwise succeeds to the business of the Company. 
 (b) Other Events. If, at any time after
the date of this Warrant, (i) the outstanding shares of Common Stock issuable upon exercise of this Warrant are changed into, or exchanged for, a different number or kind of shares or securities of the Company through a reorganization, merger,
recapitalization or reclassification which does not constitute a Change of Control, or (ii) the number of outstanding shares of such Common Stock is changed through a stock split, reverse stock split, stock dividend, stock consolidation or
similar capital adjustment, an appropriate adjustment shall be made by the Board, if necessary, in the Exercise Price and in the number or kind of shares into which this Warrant is exercisable. In making such adjustments, or in determining that no
such adjustments are necessary, the Board may rely upon the advice of counsel and accountants to the Company. 
 2.2 Notice
of Adjustment. Upon the occurrence of each adjustment or readjustment of the Exercise Price or the number and kind of securities into which this Warrant is exercisable, the Company at its expense shall promptly compute such adjustment or
readjustment in accordance with the terms hereof and furnish to the Holder a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property for which this Warrant shall be exercisable
and the Exercise Price) and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of the Holder, furnish or cause to be furnished to the Holder a certificate setting
forth (i) the 

  
 Page 3

 
Exercise Price then in effect and (ii) the number and kind of shares of capital stock and the amount, if any, of other securities, cash or property which then would be received upon the
exercise of this Warrant. 
 3. Reservation of Stock. The Company shall at all times have authorized, and reserved for
the purpose of the issue upon exercise of this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of this Warrant. 
 4. Notices of Record Date, etc. In the event the Company shall take a record of the holders of any of its Common Stock for the purpose (a) of entitling or enabling them to receive any dividend
or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right; (b) of any capital reorganization of the Company, any reclassification of the
stock of the Company or any Change of Control; or (c) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company; then, and in each such case, the Company will mail or cause to be mailed to the Holder a notice
specifying, as the case may be, (x) the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (y) the effective date on which such reorganization, reclassification,
consolidation, Change of Control, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock of the Company shall be entitled to exchange their shares for
securities or other property deliverable upon such reorganization, reclassification, consolidation, Change of Control, dissolution, liquidation or winding-up. Such notice shall be mailed at least ten days prior to the record date or effective date
for the event specified in such notice. 
 5. Exchange of Warrant. Upon the surrender by the Holder, properly endorsed,
to the Company at the principal office of the Company, the Company will issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of the Holder or as the Holder may
direct, without charge for any issuance or transfer tax or other cost incurred by the Company, calling in the aggregate on the face or faces thereof for the number of shares of capital stock (or other securities, cash and/or property) then issuable
upon exercise of this Warrant. The Company will at no time close its transfer books against the transfer of the Warrant Shares issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this
Warrant. 
 6. Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of
mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the
Company, whether or not the Warrant so lost, stolen, destroyed or mutilated shall be at any time enforceable by anyone. 

  
 Page 4

 7. Transfer of Warrant. This Warrant and all rights hereunder are transferable, in
whole, upon surrender of this Warrant with a properly executed assignment (in the form of Exhibit II hereto) at the principal office of the Company. However, as a condition to such transfer, either (a) this Warrant must be registered
under the Securities Act of 1933, as amended (the “Act”), and all applicable state securities laws with respect thereto or (b) the Company must first be furnished with an opinion of legal counsel, reasonably satisfactory to the
Company, to the effect that such transfer is exempt from the registration requirements of the Act. 
 8. Miscellaneous.

 8.1 Expiration. This Warrant shall expire at the close of business on the date which is four (4) years from the
date hereof. 
 8.2 Restrictive Legend. This Warrant, any Warrant issued upon transfer of this Warrant and the shares of
Common Stock issued upon exercise of this Warrant shall be imprinted with substantially the following legend, in addition to any legends required under applicable state securities laws: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR
UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL
APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS.” 

8.3 No Voting Rights. Nothing contained in this Warrant shall be construed as conferring upon Holder by virtue of holding this
Warrant (i) the right to vote or to consent as a shareholder in respect of meetings of shareholders for the election of directors of the Company or any other matter, (ii) the right to receive dividends or (iii) any other rights as a
shareholder of the Company. 
 8.4 Compliance with Securities Laws. Holder agrees to exercise and transfer (to the extent
permitted pursuant to Section 7 hereof) this Warrant in compliance with all applicable federal and state securities laws and agrees to cooperate with the Company in taking any and all action which may be deemed necessary or desirable to ensure
such compliance, including, without limitation, the execution and delivery of one or more documents as requested by the Company representing as to certain matters and acknowledging the restricted nature of the Common Stock to be issued. 

  
 Page 5

 8.5 Modification And Waiver. This Warrant and any provision hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement is sought. 

8.6 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday or a Sunday or a legal holiday. 

8.7 Successors and Assigns. This Warrant shall be binding upon any successors or assigns of the Company. 

8.8 Notices. All notices, requests, consents and demands with respect to this Warrant shall be made in writing and shall be deemed
effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five days after
having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All
communications shall be sent to the Company at 2251 Rutherford Road, Carlsbad, CA 92008, and to Holder at the applicable address set forth on the applicable signature page to the Subscription Agreement or at such other address as the Company or
Holder may designate by ten (10) days advance written notice to the other parties hereto. 
 8.9 Governing Law. This
Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the jurisdiction of incorporation of the Company, without regard to its principles of choice of law. 

  
 Page 6

 [ Signature Page to Warrant to Purchase Common Stock ] 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed and issued by its duly authorized representative on the date first
above written. 
  

			
	AUTOGENOMICS, INC.
		
	By:	 	 /s/ Fareed Kureshy

		 	Fareed Kureshy,
		 	Its President and CEO

  
 Page 7

 Schedule to Exhibit 10.15 

The following common stock warrants are substantially identical in all material respects to the representative warrant to which this
schedule is attached and which is filed as an exhibit to AutoGenomics, Inc.’s registration statement on Form S-1 (the “Registration Statement”), except as to the parties thereto, dates of issuance, number of warrant shares,
exercise prices and expiration dates set forth below. These other common stock warrants are not being filed with the Registration Statement, pursuant to Instruction 2 to Item 601 of Regulation S-K promulgated under the Securities Exchange
Act of 1934, as amended. 
  

															
	 Number
	  	 Holder
	  	 Date of Issuance
	  	Warrant Shares	 	  	Exercise Price
(per share)	 	  	 Expiration Date

	201004-001	  	Levin Family Revocable Trust	  	April 15, 2010	  	 	42,600	  	  	$	5.00	  	  	April 15, 2015
	201004-002	  	Heiligbrodt Family Partnership	  	April 15, 2010	  	 	142,000	  	  	$	5.00	  	  	April 15, 2015
	201004-003	  	Kentor Trust U/A dated 9/18/2002	  	April 15, 2010	  	 	71,000	  	  	$	5.00	  	  	April 15, 2015
	201004-004	  	God’s Gift	  	April 15, 2010	  	 	142,000	  	  	$	5.00	  	  	April 15, 2015
	201004-005	  	Belmont Insurance Company, Inc.	  	April 15, 2010	  	 	28,400	  	  	$	5.00	  	  	April 15, 2015
	201004-006	  	Argus Reinsurance, Ltd.	  	April 15, 2010	  	 	71,000	  	  	$	5.00	  	  	April 15, 2015
	201004-007	  	Strader Family Trust dated April 25, 2005	  	April 15, 2010	  	 	28,400	  	  	$	5.00	  	  	April 15, 2015
	201004-008	  	Bubalo Family Trust	  	April 15, 2010	  	 	28,400	  	  	$	5.00	  	  	April 15, 2015
	201004-009	  	Testman Trust	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-010	  	Terrence A. Noonan	  	April 15, 2010	  	 	7,100	  	  	$	5.00	  	  	April 15, 2015
	201004-011	  	Laurence M Demers	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-012	  	Zurlo Investment Trust	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-013	  	Kentor Trust U/A Trust dated 9/18/2002	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-014	  	Linda Formo Brandes Trust	  	April 15, 2010	  	 	71,000	  	  	$	5.00	  	  	April 15, 2015
	201004-015	  	AR Properties	  	April 15, 2010	  	 	284,000	  	  	$	5.00	  	  	April 15, 2015
	201004-016	  	Helen Lovaas 2006 Irrevocable Trust FBO Theresa Bell	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-017	  	Helen Lovaas 2006 Irrevocable Trust FBO Cindy Westwood	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-018	  	Helen Lovaas 2006 Irrevocable Trust FBO Kathy Redenius	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-019	  	Helen Lovaas 2006 Irrevocable Trust FBO Daniel Lovaas	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-020	  	Helen Lovaas 2006 Irrevocable Trust FBO Frank Bartlett	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015

															
	 Number
	  	 Holder
	  	 Date of Issuance
	  	Warrant Shares	 	  	Exercise Price
(per share)	 	  	 Expiration Date

	201004-021	  	Helen Lovaas 2006 Irrevocable Trust Trust FBO Christine Fennell	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-022	  	Ulrich Frindt Family Trust U/T/A dated October 31, 2002	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-023	  	Jason Livingston & Paula Livingston Community Property	  	April 15, 2010	  	 	28,400	  	  	$	5.00	  	  	April 15, 2015
	201004-024	  	R & E Lunn Revocable Trust dated March 10, 2004	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-025	  	Levin Family Revocable Trust dated February 22, 2007	  	April 15, 2010	  	 	28,400	  	  	$	5.00	  	  	April 15, 2015
	201004-026	  	Rue Family Trust	  	April 15, 2010	  	 	71,000	  	  	$	5.00	  	  	April 15, 2015
	201004-027	  	IAS Management, LLC	  	April 15, 2010	  	 	71,000	  	  	$	5.00	  	  	April 15, 2015
	201004-028	  	Cyndy Reinking	  	April 15, 2010	  	 	71,000	  	  	$	5.00	  	  	April 15, 2015
	201004-029	  	Joseph P. Sullivan	  	April 15, 2010	  	 	2,840	  	  	$	5.00	  	  	April 15, 2015
	201004-030	  	Harold F. McGrath, Trustee of the McGrath Family Trust	  	April 15, 2010	  	 	42,600	  	  	$	5.00	  	  	April 15, 2015
	201004-031	  	Van Fleet Family Trust	  	April 15, 2010	  	 	14,200	  	  	$	5.00	  	  	April 15, 2015
	201004-033	  	Thomas R. Testman	  	April 15, 2010	  	 	15,620	  	  	$	5.00	  	  	April 15, 2015
	201011-001	  	National Healthcare Services	  	March 30, 2009	  	 	142,000	  	  	$	3.00	  	  	January 31, 2016
	201011-002	  	National Healthcare Services	  	June 26, 2009	  	 	142,000	  	  	$	3.00	  	  	January 31, 2016
	201011-003	  	National Healthcare Services	  	December 8, 2009	  	 	142,000	  	  	$	3.00	  	  	January 31, 2016
	201011-004	  	National Healthcare Services	  	September 9, 2008	  	 	142,000	  	  	$	3.00	  	  	January 31, 2016
	201012-001	  	Laurence M. Demers	  	December 20, 2010	  	 	30,000	  	  	$	3.00	  	  	December 20, 2015
	201012-002	  	The Testman Trust	  	December 21, 2010	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201012-003	  	William Davidson	  	December 30, 2010	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201101-001	  	AR Properties	  	January 12, 2011	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201101-002	  	James Mamakos	  	January 21, 2011	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201102-001	  	Lauro Administrative Trust U/T/D dated May 9, 1980	  	February 28, 2011	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201102-002	  	The Testman Trust U/A Dtd 07/27/1982	  	February 22, 2011	  	 	15,000	  	  	$	3.00	  	  	December 31, 2015
	201102-003	  	Thomas Reise	  	February 23, 2011	  	 	15,000	  	  	$	3.00	  	  	December 31, 2015

															
	 Number
	  	 Holder
	  	 Date of Issuance
	  	Warrant Shares	 	  	Exercise Price
(per share)	 	  	 Expiration Date

	201103-001	  	Roger Ian MacFarlane	  	March 22, 2011	  	 	60,000	  	  	$	3.00	  	  	March 31, 2016
	201103-002	  	Rukhsana N. Bukhari	  	March 30, 2011	  	 	30,000	  	  	$	3.00	  	  	March 31, 2016
	201105-001	  	The Testman Trust	  	May 3, 2011	  	 	30,000	  	  	$	3.00	  	  	May 31, 2016
	201105-002	  	A R Properties	  	May 17, 2011	  	 	60,000	  	  	$	3.00	  	  	May 31, 2016
	201108-001	  	Tregales Group Ltd	  	August 8, 2011	  	 	1,300,000	  	  	$	3.00	  	  	August 8, 2016
	201012-001	  	Laurence M. Demers	  	December 20, 2010	  	 	30,000	  	  	$	3.00	  	  	December 20, 2015
	201012-002	  	The Testman Trust	  	December 21, 2010	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201012-003	  	William Davidson	  	December 30, 2010	  	 	30,000	  	  	 	3.00	  	  	December 31, 2015
	201101-001	  	AR Properties	  	January 12, 2011	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201101-002	  	James Mamakos	  	January 21, 2011	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201102-001	  	Lauro Administrative Trust U/T/D dated May 9, 1980	  	February 28, 2011	  	 	30,000	  	  	$	3.00	  	  	December 31, 2015
	201102-002	  	The Testman Trust U/A Dtd 07/27/1982	  	February 22, 2011	  	 	15,000	  	  	$	3.00	  	  	December 31, 2015
	201102-003	  	Thomas Reise	  	February 23, 2011	  	 	15,000	  	  	$	3.00	  	  	December 31, 2015
	201103-001	  	Roger Ian MacFarlane	  	March 22, 2011	  	 	60,000	  	  	$	3.00	  	  	March 31, 2016
	201103-002	  	Rukhsana N. Bukhari	  	March 30, 2011	  	 	30,000	  	  	$	3.00	  	  	March 31, 2016
	201105-001	  	The Testman Trust	  	May 3, 2011	  	 	30,000	  	  	$	3.00	  	  	May 31, 2016
	201105-002	  	A R Properties	  	May 17, 2011	  	 	60,000	  	  	$	3.00	  	  	May 31, 2016Warrant to Purchase Common Stock (No. 200908-001)

 Exhibit 10.16 
 THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION
SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS. 
  

			
	WARRANT NO. 200908-001	 	Date: August 19, 2009

 WARRANT TO PURCHASE COMMON STOCK 
 AutoGenomics, Inc., a Delaware corporation (the “Company”), hereby certifies that Scott GRAT No. 5 (the “Holder”), is entitled to purchase, on the terms and
conditions contained herein, 568,000 fully paid, validly issued and nonassessable shares (the “Warrant Shares”) of common stock, no par value, of the Company (the “Common Stock”), at an initial exercise price of
$4.00 per Warrant Share, as may be adjusted pursuant to the terms hereof (the “Exercise Price”). This Warrant has been approved by the Board of Directors of the Company and is issued pursuant to the terms of that certain
Subscription Agreement, dated as of the date hereof, by and between the Company and the Holder (the “Subscription Agreement”). The number of Warrant Shares and the Exercise Price are subject to adjustment as provided in
Section 2 below. Capitalized terms used herein not otherwise defined shall have the meanings set forth in Section 8.1. 
 This Warrant is subject to the following terms and conditions: 
 1.
Exercisability and Exercise. 
 1.1 Method of Exercise. This Warrant may be exercised in whole, or in part, at the
option of the Holder at any time and from time to time from the one (1) year anniversary of the date hereof through and including the five (5) year anniversary of the date hereof, provided that this Warrant may be exercised immediately in
connection with a Liquidity Event, by delivering to the Company payment of the aggregate Exercise Price for the Warrant Shares being purchased by check or wire transfer, together with an executed Notice of Exercise in the form attached as Exhibit
I hereto. 
 1.2 Effectiveness of Exercise; Procedure. The exercise of this Warrant shall be deemed to have been
effected immediately prior to the close of business on the day on which the Holder delivers the Notice of Exercise to the Company together with payment of the Exercise Price and satisfies all of the requirements of this Section 1. Upon such
exercise, the Holder will be deemed a shareholder of record of the Warrant Shares with all rights of a shareholder (including, without limitation, all voting rights with respect to such Warrant Shares and all rights to receive any dividends with
respect to such Warrant Shares). In the event of any exercise of the rights represented by this 

  
 Page 1

 
Warrant, certificates for the shares of Common Stock so purchased shall be delivered to the Holder within a reasonable time by the transfer agent of the Company by crediting the account of the
Holder’s broker with The Depositary Trust Company through its Deposit Withdrawal Agent Commission system if the Company is a participant in such system, and otherwise by physical delivery to the address specified in the Notice of Exercise. The
Company shall not be required to issue fractional shares upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Holder shall be entitled, at its option, to receive either (a) a
cash payment equal to the excess of the fair market value, as determined by the Board of Directors of the Company in good faith, for such fractional share above the Exercise Price for such fractional share (as mutually determined by the Company and
the Holder) or (b) a whole share if the Holder tenders the Exercise Price for one whole share. 
 2. Adjustments.

 2.1 Reorganizations, Mergers, Recapitalizations and Reclassifications. 

(a) Change of Control. If at any time a Change of Control (as defined below) occurs and, pursuant to the terms of such Change of
Control, shares of common stock of the successor or acquiring corporation, or any cash, shares of stock or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition to or in lieu
of common stock of the successor or acquiring corporation (“Other Property”), are to be received by or distributed to the holders of Common Stock of the Company, then the Holder shall have the right thereafter to receive upon
exercise of this Warrant (and this Warrant shall thereafter be exercisable only for) the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and Other Property receivable
upon or as a result of such Change of Control by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Change of Control. In case of any such Change of Control, the successor or acquiring
corporation (if other than the Company) shall expressly assume the due and punctual observance and performance of each and every covenant and condition of this Warrant to be performed and observed by the Company and all the obligations and
liabilities hereunder, subject to such modifications as may be deemed appropriate (as determined in good faith by resolution of the Board of Directors of the Company) in order to provide for adjustments of the Warrant Shares for which this Warrant
is exercisable which shall be as nearly equivalent as practicable to the adjustments provided for in this Section 2.1(a). For purposes of this Section 2.1(a), “common stock of the successor or acquiring corporation” shall include
stock of such corporation of any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject to redemption. The foregoing provisions of this Section 2.1(a) shall similarly
apply to any successive Change of Control. As used in this Warrant, a “Change of Control” shall mean (i) a transaction or series of transactions (other than an offering of common stock of the Company to the general public
through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Securities Exchange
Act of 1934, as amended from time to time (the “Exchange Act”)) (other than the Company, any 

  
 Page 2

 
of its subsidiaries, an employee benefit plan maintained by the Company or any of its subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is
controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined
voting power of the Company’s securities outstanding immediately after such acquisition; or (ii) the consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more
intermediaries) of (A) a merger, consolidation, reorganization or business combination, (B) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or
(C) the acquisition of assets or stock of another entity, in each case other than a transaction (1) which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by
remaining outstanding or by being converted into voting securities of the Successor Entity (as defined below)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities
immediately after the transaction, and (2) after which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or
group shall be treated for purposes of this Section 2.1(a)(ii)(C)(2) as beneficially owning 50% or more of combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the
transaction. As used in this Section 2.1(a)(ii)(C), the “Successor Entity” shall mean, as applicable, the Company or the person that, as a result of the Change of Control, controls, directly or indirectly, the Company or owns,
directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company. 
 (b) Issuance of Additional Stock below Exercise Price. If the Company issues (or is deemed to have issued pursuant to Section 2.1(b)(iv) below) after the date hereof (the “Commencement
Date”), any Additional Stock without consideration or for consideration per share less than the Exercise Price applicable to any unissued Warrant Shares in effect immediately prior to the issuance of such Additional Stock, the Exercise
Price for the Warrant Shares in effect immediately prior to each such issuance shall automatically be adjusted as set forth in this Section 2.1(b), unless otherwise provided in this Section 2.1(b) 

(i) Adjustment Formula. Whenever the Exercise Price applicable to unissued Warrant Shares is adjusted pursuant to
this Section 2.1(b), the new Exercise Price shall be determined by multiplying the Exercise Price for such Warrant Shares then in effect by a fraction, (x) the numerator of which shall be an amount equal to the sum of (i) the number
of shares of Common Stock outstanding (or deemed outstanding pursuant to the provisions of Section 2.1(b)(iv) below) immediately prior to such issuance (the “Fully Diluted Outstanding Common Stock”), and (ii) the number of
shares of Common Stock which the aggregate consideration received by the Company for such issuance would purchase at the applicable Exercise Price in effect immediately prior to the issuance of such Additional Stock for such unissued Warrant Shares;
and (y) the 

  
 Page 3

 
denominator of which shall be the number of shares of Fully Diluted Outstanding Common Stock plus the number of shares of such Additional Stock issued (or deemed issued pursuant to the provisions
of Section 2.1(b)(iv) below). 
 (ii) No Fractional Adjustments. No adjustment of the Exercise Price
for unissued Warrant Shares pursuant to Section 2.1(b) shall be made in an amount less than one cent per share, provided that any adjustments which are not required to be made by reason of this sentence shall be carried forward and shall be
either taken into account in any subsequent adjustment made prior to three (3) years from the date of the event giving rise to the adjustment being carried forward, or shall be made at the end of three (3) years from the date of the event
giving rise to the adjustment being carried forward. 
 (iii) Determination of Consideration. In the case
of the issuance of Common Stock for cash, the consideration shall be deemed to be the amount paid therefor before deducting any reasonable discounts, commissions or other expenses allowed, paid or incurred by the Company for any underwriting or
otherwise in connection with the issuance and sale thereof. In the case of the issuance of Common Stock for consideration in whole or in part other than cash, the consideration other than cash shall be deemed to be the fair market value thereof as
determined in good faith by the Company’s Board of Directors. 
 (iv) Deemed Issuances of Common
Stock. In the case of the issuance of options to purchase or rights to subscribe for Common Stock, securities by their terms convertible into or exchangeable for Common Stock or options to purchase or rights to subscribe for such convertible or
exchangeable securities, the following provisions shall apply for all purposes of this Section 2.1(b): 

(A) The aggregate maximum number of shares of Common Stock deliverable upon exercise (assuming the satisfaction of any
conditions to exercisability, including without limitation, the passage of time, but without taking into account potential antidilution adjustments) of such options to purchase or rights to subscribe for Common Stock shall be deemed to have been
issued at the time such options or rights were issued and for a consideration equal to the consideration (determined in the manner provided in Section 2.1(b)(iii)), if any, received, by the Company upon the issuance of such options or rights
(without taking into account potential antidilution adjustments) plus the minimum exercise price provided in such options or rights for the Common Stock covered thereby. 

(B) The aggregate maximum number of shares of Common Stock deliverable upon conversion of or exchange (assuming the
satisfaction of any conditions to exercisability, including without limitation, the passage of time, but without taking into account potential antidilution adjustments) for any such convertible or exchangeable

  
 Page 4

 
securities or upon the exercise of options to purchase or rights to subscribe for such convertible or exchangeable securities and subsequent conversion or exchange thereof shall be deemed to have
been issued at the time such securities were issued or such options or rights were issued and for a consideration equal to the consideration, if any, received by the Company for any such securities and related options or rights (excluding any cash
received on account of accrued interest or accrued dividends), plus the minimum additional consideration, if any, to be received by the Company (without taking into account potential antidilution adjustments) upon the conversion or exchange of such
securities or the exercise of any related options or rights (the consideration in each case to be determined in the manner provided in Section 2.1(b)(iii)). 

(C) In the event of any change in the number of shares of Common Stock deliverable or in the consideration payable to the
Company upon exercise of such options or rights or upon conversion of in exchange for such convertible or exchangeable securities, including, but not limited to, a change resulting from the antidilution provisions thereof, the Exercise Price
applicable to the unissued Warrant Shares, to the extent in any way affected by or computed using such options, right or securities, shall be recomputed to reflect such change, but no further adjustment shall be made for the actual issuance of
Common Stock or any payment of such consideration upon the exercise of any such options or rights or the conversion or exchange of such securities. 
 (D) Upon the expiration of such options or rights, the termination of any such rights to convert or exchange or the expiration of any options or rights related to such convertible or exchangeable
securities, the Exercise Price applicable to such unissued Warrant Shares shall, to the extent in any way affected by or computed using such options, rights or securities or options or rights related to such securities, be recomputed to reflect the
issuance of only the number of shares of Common Stock (and convertible or exchangeable securities which remain in effect) actually issued upon the exercise of such options or rights, upon the conversion or exchange of such securities or upon the
exercise of the options or rights related to such securities. 
 (E) The number of shares of Common Stock deemed
issued and the consideration deemed paid therefor pursuant to Section 2.1(b)(iv)(A) and Section 2.1(b)(iv)(B) shall be appropriately adjusted to reflect any change, termination or expiration of the type described in either
Section 2.1(b)(iv)(C) or Section 2.1(b)(iv)(D). 
 (v) No Increase in Exercise Price.
Notwithstanding any other provisions of this Section 2.1(b), except to the limited extent provided for in Section 2.1(b)(iv)(D) and Section 2.1(b)(iv)(E), no adjustment of the Exercise Price applicable to unissued Warrant Shares
pursuant to this Section 2.1(b) (but 

  
 Page 5

 
for the avoidance of doubt expressly excluding Sections 2.1(a) and (c)) shall have the effect of increasing such Exercise Price above the Exercise Price applicable to such unissued Warrant Shares
in effect immediately prior to such adjustment. 
 (c) Other Events. If, at any time after the date of this Warrant,
(i) the outstanding shares of Common Stock issuable upon exercise of this Warrant are changed into, or exchanged for, a different number or kind of shares or securities of the Company through a reorganization, merger, recapitalization or
reclassification which does not constitute a Change of Control, or (ii) the number of outstanding shares of such Common Stock is changed through a stock split, reverse stock split, stock dividend, stock consolidation or similar capital
adjustment, an appropriate adjustment shall be made by the Board in the Exercise Price and in the number or kind of shares into which this Warrant is exercisable. In making such adjustments, or in determining that no such adjustments are necessary,
the Board may rely upon the advice of counsel and accountants to the Company. 
 2.2 Notice of Adjustment. Upon the
occurrence of each adjustment or readjustment of the Exercise Price or the number and kind of securities into which this Warrant is exercisable, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the
terms hereof and furnish to the Holder a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property for which this Warrant shall be exercisable and the Exercise Price) and showing
in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of the Holder, furnish or cause to be furnished to the Holder a certificate setting forth (i) the Exercise Price
then in effect and (ii) the number and kind of shares of capital stock and the amount, if any, of other securities, cash or property which then would be received upon the exercise of this Warrant. 

3. Reservation of Stock. The Company shall at all times have authorized, and reserved for the purpose of the issue upon exercise
of this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of this Warrant. 
 4. Notices
of Record Date, etc. In the event the Company shall take a record of the holders of any of its Common Stock for the purpose (a) of entitling or enabling them to receive any dividend or other distribution, or to receive any right to
subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right; (b) of any capital reorganization of the Company, any reclassification of the stock of the Company or any Change of Control; or
(c) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company; then, and in each such case, the Company will mail or cause to be mailed to the Holder a notice specifying, as the case may be, (x) the record date
for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (y) the effective date on which such reorganization, reclassification, consolidation, Change of Control, dissolution, liquidation
or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock of the Company shall be entitled to exchange their shares for securities or other property deliverable upon such reorganization,
reclassification, 

  
 Page 6

 
consolidation, Change of Control, dissolution, liquidation or winding-up. Such notice shall be mailed at least ten days prior to the record date or effective date for the event specified in such
notice. 
 5. Exchange of Warrant. Upon the surrender by the Holder, properly endorsed, to the Company at the principal
office of the Company, the Company will issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of the Holder or as the Holder may direct, without charge for any
issuance or transfer tax or other cost incurred by the Company, calling in the aggregate on the face or faces thereof for the number of shares of capital stock (or other securities, cash and/or property) then issuable upon exercise of this Warrant.
The Company will at no time close its transfer books against the transfer of the Warrant Shares issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this Warrant. 

6. Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the Company, whether
or not the Warrant so lost, stolen, destroyed or mutilated shall be at any time enforceable by anyone. 
 7. Transfer of
Warrant. This Warrant and all rights hereunder are transferable, in whole, upon surrender of this Warrant with a properly executed assignment (in the form of Exhibit II hereto) at the principal office of the Company. However, as a
condition to such transfer, either (a) this Warrant must be registered under the Securities Act of 1933, as amended (the “Act”), and all applicable state securities laws with respect thereto or (b) the Company must first
be furnished with an opinion of legal counsel, reasonably satisfactory to the Company, to the effect that such transfer is exempt from the registration requirements of the Act. 

8. Miscellaneous. 
 8.1 Certain Definitions. 
 “Additional Stock” shall mean
any shares of Common Stock issued (or deemed to have been issued) pursuant to Section 2.1(b)(iv) by the Company after the Commencement Date other than: 
 (a) Common Stock issued pursuant to a transaction described in Section 2.1(c) hereof; 
 (b) Common Stock issuable or issued from time to time to employees, consultants, officers or directors of the Company (or of any affiliate of the 

  
 Page 7

 
Company) pursuant to the Company’s 2000 Equity Incentive Plan or pursuant to any other plan to the extent that such issuance is approved by the Board of Directors of the Company; 

(c) Common Stock or Preferred Stock of the Company issued pursuant to the conversion or exercise of convertible or exercisable
securities outstanding as of the Commencement Date, including without limitation, options, warrants, notes or other rights to acquire Common Stork or Preferred Stock; 
 (d) Series C Preferred Stock of the Company issued, or issuable upon exercise of warrants to purchase Series C Preferred Stock of the Company issued in connection with the issuance and sale of Series C
Preferred Stock of the Company, or issued after the Commencement Date for consideration per share at least equal to the Series C Conversion Price (as defined in the Company’s Certificate of Incorporation in effect as of the date hereof); and

 (e) Capital stock, or options or warrants to purchase capital stock, issued pursuant to or in connection with any of the
following transactions or arrangements, the terms of which are approved by the Board of Directors of the Company; (1) commercial credit arrangements, equipment financings or similar transactions; (2) bona fide acquisitions, mergers or
similar transactions in which such capital stock, or options or warrants to purchase capital stock, are issued for consideration other than cash; and (3) transactions involving issuances to customers, vendors or strategic, partners of the
Company. 
 “Liquidity Event” shall mean the occurrence of either (a) a transaction or series of
transactions (whether structured as a stock sale, merger, consolidation, reorganization, asset sale or otherwise) which results in the sale or transfer of more than a majority of the assets of the Company and its subsidiaries (determined based on
value) or a majority of the capital stock of the Company; or (b) an underwritten public offering of the Common Stock pursuant to an effective registration statement filed with the Securities and Exchange Commission (but expressly excluding
registration statement no. 333-152512) which yields at least $50,000,000 of net cash proceeds to the Company. 
 8.2
Expiration. This Warrant shall expire at the close of business on the date five (5) years from the date hereof. 

8.3 Restrictive Legend. This Warrant, any Warrant issued upon transfer of this Warrant and the shares of Common Stock issued upon
exercise of this Warrant shall be imprinted with substantially the following legend, in addition to any legends required under applicable state securities laws: 
 “THE SECURITIES REPRESENTED BY THIS [WARRANT CERTIFICATE] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES

  
 Page 8

 
HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A CURRENT AND EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ALL
APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES, OR AN OPINION SATISFACTORY TO THE ISSUER AND ITS COUNSEL TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND ALL APPLICABLE STATE SECURITIES LAWS.” 

8.4 No Voting Rights. Nothing contained in this Warrant shall be construed as conferring upon Holder by virtue of holding this
Warrant (i) the right to vote or to consent as a shareholder in respect of meetings of shareholders for the election of directors of the Company or any other matter, (ii) the right to receive dividends or (iii) any other rights as a
shareholder of the Company. 
 8.5 Compliance with Securities Laws. Holder agrees to exercise and transfer (to the extent
permitted pursuant to Section 7 hereof) this Warrant in compliance with all applicable federal and state securities laws and agrees to cooperate with the Company in taking any and all action which may be deemed necessary or desirable to ensure
such compliance, including, without limitation, the execution and delivery of one or more documents as requested by the Company representing as to certain matters and acknowledging the restricted nature of the Common Stock to be issued. 

8.6 Modification And Waiver. This Warrant and any provision hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement is sought. 
 8.7 Saturdays, Sundays, Holidays, etc.
If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next
succeeding day not a Saturday or a Sunday or a legal holiday. 
 8.8 Successors and Assigns. This Warrant shall be
binding upon any successors or assigns of the Company. 
 8.9 Notices. All notices, requests, consents and demands with
respect to this Warrant shall be made in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the
recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at 2251 Rutherford Road, Carlsbad, CA 92008, and to Holder at the applicable address set forth on the applicable signature page to
the Subscription Agreement or at such other address as the Company or Holder may designate by ten (10) days advance written notice to the other parties hereto. 

  
 Page 9

 8.10 Governing Law. This Warrant shall be construed and enforced in accordance with,
and the rights of the parties shall be governed by, the laws of California, without regard to its principles of choice of law. 

(Signature Page Follows) 

  
 Page 10

 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed and issued by its duly authorized
representative on the date first above written. 
  

			
	AUTOGENOMICS, INC.
		
	By:	 	 /s/ Fareed Kureshy

		 	Fareed Kureshy,
		 	Its President and CEO

  
 (Signature
Page to Warrant)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]